ANI Pharmaceuticals (ANIP)

Add to Watchlists
Create an Alert
25.55 +0.76  +3.07% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
ANIP Price Chart
View All Events

ANIP Events

Date Type Description
Feb 18 Earnings ANI Pharmaceuticals Inc Q4 2013 Earning Result. Estimate: 0.24.
Feb 18 Misc ANI Pharmaceuticals Inc Q4 2013 Earning Conference Call
Nov 07 Earnings ANI Pharmaceuticals, Inc. Announces Date for Third Quarter 2013 Earnings Release.
Aug 09 Earnings ANI Pharmaceuticals Reports Net Revenues of $6.2 Million and Adjusted Non-gaap Ebitda of $1.2 Million for the Second Quarter Ended June 30, 2013.
Jul 18 Splits Ratio: 6006000463061293:36028797018963968
May 10 Earnings Biosante Pharmaceuticals, Inc. Reports First Quarter Financial Results.
View All Performance Charts

ANIP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ANI Pharmaceuticals is up 280.2% over the last year vs S&P 500 Total Return up 20.96%, Alkermes up 48.45%, and Alexion Pharmaceuticals up 58.10%.

Get Quote for
Advertisement

Portfolio Strategies Featuring ANIP

Did ANI Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ANIP Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Minnesota
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

ANI Pharmaceuticals Inc, together with its subsidiary, is a specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals products.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ANIP 25.55 +0.76 +3.07% 246.58M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.